Daiwa Securities Group
ROIV icon

Daiwa Securities Group’s Roivant Sciences ROIV Stock Holding History

Daiwa Securities Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3M Buy
1,166,320
+1,156,301
+11,541% +$34.2M 0.08% 138
2026
Q1 		$278K Buy
10,019
+7,954
+385% +$204K ﹤0.01% 994
2025
Q4 		$45K Sell
2,065
-80
-4% -$1.58K ﹤0.01% 1123
2025
Q3 		$32K Sell
2,145
-257
-11% -$3.18K ﹤0.01% 1119
2025
Q2 		$27K Sell
2,402
-5,353
-69% -$58K ﹤0.01% 1092
2025
Q1 		$78K Sell
7,755
-195
-2% -$2.11K ﹤0.01% 985
2024
Q4 		$94K Sell
7,950
-668
-8% -$7.9K ﹤0.01% 1005
2024
Q3 		$99K Sell
8,618
-241
-3% -$2.74K ﹤0.01% 1011
2024
Q2 		$94K Sell
8,859
-2,010
-18% -$22K ﹤0.01% 1031
2024
Q1 		$115K Sell
10,869
-768
-7% -$8.28K ﹤0.01% 1040
2023
Q4 		$131K Buy
11,637
+40
+0.3% +$390 ﹤0.01% 990
2023
Q3 		$135K Hold
11,597
– – ﹤0.01% 1000
2023
Q2 		$117K Sell
11,597
-2,177
-16% -$19.5K ﹤0.01% 986
2023
Q1 		$102K Buy
13,774
+2,132
+18% +$17.6K ﹤0.01% 991
2022
Q4 		$93K Buy
11,642
+846
+8% +$4.71K ﹤0.01% 991
2022
Q3 		$35K Buy
+10,796
New +$41.8K ﹤0.01% 1078

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Daiwa Securities Group's ROIV Position: Q2 2026 in Review

Daiwa Securities Group increased its Roivant Sciences (ROIV) stake by 11,541% in Q2 2026, buying an estimated $34.2M and bringing the position to 1,166,320 shares worth $41.3M. The position accounts for 0.08% of the portfolio, ranked #138.

Daiwa Securities Group first reported a position in ROIV in Q3 2022 and has held it in 16 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Daiwa Securities Group held 1,166,320 shares of Roivant Sciences worth $41.3M as of Q2 2026.
  • Daiwa Securities Group bought 1,156,301 Roivant Sciences shares in Q2 2026, an estimated $34.2M.
  • Roivant Sciences made up 0.08% of Daiwa Securities Group's portfolio in Q2 2026, its #138 holding.
  • Daiwa Securities Group first reported a position in Roivant Sciences in Q3 2022 and has held it in 16 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.